Enhancing the QUAlity and Transparency Of health Research

Search for reporting guidelines

Use your browser's Back button to return to your search results

TIDieR-Placebo : a guide and checklist for reporting placebo and sham controls

Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
Reporting placebo or sham interventions.
Full bibliographic reference Howick J, Webster RK, Rees J, Turner R, Macdonald H, 1. Price A, Evers WMA, Bishop FL, Collins GS, Bokelmann K, Hopewell S, Knottnerus A, Lamb S, Madigan C, Napadow V, Papanikitas A, Hoffmann T. TIDieR-Placebo: a guide and checklist for reporting placebo and sham controls. PLoS Med. 2020;17(9):e1003294.
Language English
PubMed ID 32956344
Relevant URLs
(full-text if available)
The full-text of the TIDieR-Placebo reporting guideline can be accessed at: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003294
Relevant more generic / specialised reporting guidelines
(i.e. main generic guideline or extension to a generic guideline)
TIDieR: Hoffmann T, Glasziou P, Boutron I, Milne R, Perera R, Moher D, Altman D, Barbour V, Macdonald H, Johnston M, Lamb S, Dixon-Woods M, McCulloch P, Wyatt J, Chan A, Michie S. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. PMID: 24609605

TIDieR-PHP: Campbell M, Katikireddi SV, Hoffmann T, Armstrong R, Waters E, Craig P. TIDieR-PHP: a reporting guideline for population health and policy interventions. BMJ. 2018;361:k1079. PMID: 29769210

Reporting guideline website URL http://www.tidierguide.org/
Reporting guideline acronym TIDieR-Placebo
Study design Clinical trials, Experimental studies, Observational studies, Study protocols, Systematic reviews/Meta-analyses/Reviews/HTA/Overviews
Applies to the whole report or to individual sections of the report? Intervention (exposure)
Additional information Read the TIDieR Placebo Protocol (PDF).

Read a background paper: Howick J, Hoffmann T. How placebo characteristics can influence estimates of intervention effects in trials. CMAJ. 2018;190(30):E908-E911. PMID: 30061325

Record last updated on September 8, 2021


Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.

About the Library

For information about Library scope and content, identification of reporting guidelines and inclusion/exclusion criteria please visit About the Library.

Visit our Help page for information about searching for reporting guidelines and for general information about using our website.